InfuSystem Holdings, Inc. (NYSEMKT:INFU) Files An 8-K Regulation FD Disclosure

Item7.01.

On June19, 2017, InfuSystem Holdings, Inc. (the Company) issued a
press release in response to an unsolicited proposal by 22NW
Fund, LP to acquire the Company. A copy of the press release is
filed as Exhibit 99.1 hereto and is incorporated by reference
herein.

The information in this Item7.01 Regulation FD Disclosure of this
Current Report on Form 8-K and the press release attached hereto
as Exhibit 99.1 shall not be deemed filed for the purpose of
Section18 of the Securities Exchange Act of 1934, as amended, or
otherwise subject to the liabilities of such section, and shall
not be deemed to be incorporated by reference into the filings of
the Company under the Securities Act of 1933, as amended, or the
Securities Exchange Act of 1934, as amended.

InfuSystem Holdings, Inc Exhibit
EX-99.1 2 d399440dex991.htm EX-99.1 EX-99.1 Exhibit 99.1     InfuSystem Holdings,…
To view the full exhibit click here
About InfuSystem Holdings, Inc. (NYSEMKT:INFU)

InfuSystem Holdings, Inc. is a provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers and other sites of care. The Company delivers local, field-based customer support and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada. Its service is to supply electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics and hospital outpatient chemotherapy clinics for the treatment of a range of cancers, including colorectal cancer, pain management and other disease states. It sells or rents new and pre-owned pole mounted and ambulatory infusion pumps to, and provides biomedical recertification, maintenance and repair services for oncology practices, as well as other alternate site settings, including home care and home infusion providers, skilled nursing facilities, pain centers and others.